Summit Therapeutics (SMMT)’s Ivonescimab Shows Global Success—Analysts See Billions Ahead
Summit Therapeutics Inc. (NASDAQ:SMMT) is a clinical-stage biopharmaceutical company that has steadily carved out its position as one…
Browsing Tag